Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Request for Proposals (Contracts)

Title Fast-Track Proposals Direct-to-Phase II Proposals Receipt date Anticipated Awards Budget

NIH/NCI 459 – Automated Software for Point-of-Care Testing to Identify Cancer-Associated Malnutrition

 Accepted NOT Accepted 11/14/2023 2-3 Phase I: up to $400,000 for up to 12 months
Phase II: up to $2,000,000 for up to 2 years

NIH/NCI 456– Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control

 Accepted Accepted 11/14/2023 3-5 Phase I: up to $400,000 for up to 12 months
Phase II: up to $2,000,000 for up to 2 years

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) PAR-22-114 Clinical Trial Optional 01/24/2025 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) UH2, UH3 Clinical Trial Not Allowed 10/11/2023 Lynn Sorbara, Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-314 (UH3 Clinical Trials Not Allowed) UH3 10/11/2023 Lynn Sorbara, Ph.D.
Basic Research in Cancer Health Disparities PAR-21-323 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Basic Research in Cancer Health Disparities PAR-21-324 (R03 Clinical Trial Not Allowed) R03 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Basic Research in Cancer Health Disparities PAR-21-322 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Biology of Bladder Cancer PAR-22-219 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 09/08/2025 Chen Suen, Ph.D., R.Ph.
Biology of Bladder Cancer PAR-22-218 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2025 Chen Suen, Ph.D., R.Ph.
Cancer Immunoprevention Network (CIP-Net) Research Projects RFA-CA-23-029 (UG3/UH3 Clinical Trials Not Allowed) UH3, UG3 07/04/2024 Altaf Mohammed, Ph.D.
Cancer Prevention and Control Clinical Trials Grant Program PAR-21-035 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/08/2024 Brandy Heckman-Stoddard, Ph.D., M.P.H.